Want a Prescription for Eyelashes?
Viagra was initially intended for the treatment of angina, but after Pfizer noticed in Phase I clinical trials that subjects were getting erections as a side effect, the pharmaceutical giant decided to market it as a treatment for erectile dysfunction. Now, as the Wall Street Journal’s Health blog reports, another drug has gained a new indication based on desirable (at least for some people) side effects:
You thought there was a drug for everything. But — at least until today — there wasn’t.
Allergan said today that the FDA has approved its drug Latisse for “hypotrichosis of the eyelashes.” The company, which also sells Botox, helpfully explains that this is “another name for having inadequate or not enough eyelashes.” It’s a prescription drug that’s applied daily.
As the WSJ notes, Latisse is the same compound the company sells under the brand name Lumigan to treat glaucoma, an eye disease. They noticed during clinical trials that one of the drug’s side effects was making eyelashes longer, thicker and darker.
Some more research, an FDA panel and a new cosmetic drug is born.